Postpartum applications represent 86.8%, hospital pharmacies 63.7%, injectable products 94.2%, hospitals 69.0% and intravenous route 57.0% in 2026. The oxytocin market is estimated at USD 117.1 million in 2026, is projected to reach USD 268.4 million by 2036 and is forecast to post an 8.6% CAGR between 2026 and 2036.